Class 4 caution in use-Linezolid 600mg tablets

Sandoz Ltd. has informed the MHRA that there is missing safety information in the Patient Information Leaflet (PIL) and Summary of Product Characteristics (SmPC) for Linezolid 600 mg film-coated tablets.

MHRA Drug alert date: 10th October 2024

MHRA drug alert link https://www.gov.uk/drug-device-alerts/class-4-medicines-defect-information-sandoz-ltd-dot-linezolid-600-mg-film-coated-tablets-el-24-a-slash-48?utm_medium=email&utm_campaign=govuk-notifications-topic&utm_source=025d6ab9-9885-40e6-ab69-13bedf8bcd94&utm_content=immediately

This is a caution in use only we are not accepting stock returns

Further Information

For medical information queries, please contact: sandozgb@EU.propharmagroup.com, Telephone: +44 1276 698 101.

For stock control queries, please contact: sales.sandoz-gb@sandoz.com, Telephone: +44 1276 698607.